Abstract

Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2020 - Volume 24, Number 2

Page(s): 131

Download in electronic PDF format for $75
  • Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Page 1

Abstract

A formulation for preparing Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • cholecalciferol
  • formulation
  • stability
  • storage temperature
  • vitamin D deficiency
  • rickets
  • familial hypophosphatemia
  • hypoparathyroidism
  • Fanconi syndrome
  • dietary supplement
  • nutritional supplementation
  • calcium uptake

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • NUTRITION AND NUTRICEUTICALS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2020
Pg. 131
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 243
Cholecalciferol 40,000-IU/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 489
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 55
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2019
Pg. 192-199
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Author(s): Riepl Mike
Jul/Aug 2019
Pg. 281-287
Mean Kinetic Temperature for Controlled Room Temperature Drug Storage: Official Definitions and Example Calculations
Author(s): Newton David W
Mar/Apr 2020
Pg. 138
Topiramate 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2022
Pg. 149
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Mar/Apr 2020
Pg. 133
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 134
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 135
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 136
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 137
Terbinafine 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 130
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 82-85
Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution)
Author(s): Voudrie Mark A II, Allen D Brett
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Mar/Apr 2021
Pg. 145
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 417
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C